Barbara S. Wiggins

4.3k total citations · 3 hit papers
40 papers, 1.8k citations indexed

About

Barbara S. Wiggins is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Barbara S. Wiggins has authored 40 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 11 papers in Internal Medicine and 10 papers in Surgery. Recurrent topics in Barbara S. Wiggins's work include Venous Thromboembolism Diagnosis and Management (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Barbara S. Wiggins is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Barbara S. Wiggins collaborates with scholars based in United States, Belgium and Canada. Barbara S. Wiggins's co-authors include Robert L. Page, Sarah A. Spinler, Pamela B. Morris, Carol W. Holtzman, Joseph J. Saseen, David P. Wacker, Wendy K. Berg, Paul P. Dobesh, Ty J. Gluckman and Deborah Siegal and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Critical Care Medicine.

In The Last Decade

Barbara S. Wiggins

36 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants

2017 263 citations Gordon F. Tomaselli, Kenneth W. Mahaffey et al. Journal of the American College of Cardiology profile →
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association

2016 239 citations Barbara S. Wiggins, Joseph J. Saseen et al. profile →
2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants

2020 201 citations Gordon F. Tomaselli, Kenneth W. Mahaffey et al. Journal of the American College of Cardiology profile →

Peers

Countries citing papers authored by Barbara S. Wiggins

Since Specialization

Citations

This map shows the geographic impact of Barbara S. Wiggins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara S. Wiggins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara S. Wiggins more than expected).

Fields of papers citing papers by Barbara S. Wiggins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara S. Wiggins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara S. Wiggins. The network helps show where Barbara S. Wiggins may publish in the future.

Co-authorship network of co-authors of Barbara S. Wiggins

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara S. Wiggins. A scholar is included among the top collaborators of Barbara S. Wiggins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara S. Wiggins. Barbara S. Wiggins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Select drug-drug interactions with colchicine and cardiovascular medications: A review 2022 ·American Heart Journal ·Dave L. Dixon, Jaideep Patel, (unknown), Azita H. Talasaz, Antonio Abbate, Barbara S. Wiggins	6
2	Human Angiopoietin-like Protein 3/ANGPTL3 Antibodies: Adding to the Armamentarium in the Management of Dyslipidemia 2021 ·Journal of Cardiovascular Pharmacology ·Barbara S. Wiggins	0
3	Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Weighing ≥ 120 Kilograms versus 60–120 Kilograms 2021 ·American Journal of Cardiovascular Drugs ·(unknown), (unknown), Barbara S. Wiggins	7
4	Select Drug-Drug Interactions With Direct Oral Anticoagulants 2020 ·Journal of the American College of Cardiology ·Barbara S. Wiggins, Dave L. Dixon, Ron Neyens, Robert L. Page, Ty J. Gluckman	94
5	2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants breakdown → 2020 ·Journal of the American College of Cardiology ·Gordon F. Tomaselli, Kenneth W. Mahaffey, Adam Cuker, Paul P. Dobesh, John Doherty, John W. Eikelboom, Roberta Florido, Ty J. Gluckman, William J. Hucker, Roxana Mehran, Steven R. Messé, Alexander C. Perino, Fátima Rodríguez, Ravi Sarode, Deborah Siegal, Barbara S. Wiggins	201
6	Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review 2020 ·Advances in Therapy ·Daniel E. Hilleman, Barbara S. Wiggins, Michael B. Bottorff	30
7	2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment 2018 ·Journal of the American College of Cardiology ·Rajat S. Barua, Nancy A. Rigotti, Neal L. Benowitz, K. Michael Cummings, (unknown), Pamela B. Morris, Elizabeth V Ratchford, Linda Sarna, Eric C. Stecker, Barbara S. Wiggins	197
8	Evolocumab: Considerations for the Management of Hyperlipidemia 2018 ·Current Atherosclerosis Reports ·Barbara S. Wiggins, (unknown), Helina Kassahun, Armando Lira, Ransi Somaratne	11
9	2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants breakdown → 2017 ·Journal of the American College of Cardiology ·Gordon F. Tomaselli, Kenneth W. Mahaffey, Adam Cuker, Paul P. Dobesh, John Doherty, John W. Eikelboom, Roberta Florido, William J. Hucker, Roxana Mehran, Steven R. Messé, Charles V. Pollack, Fátima Rodríguez, Ravi Sarode, Deborah Siegal, Barbara S. Wiggins	263
10	Gemfibrozil in Combination with Statins—Is It Really Contraindicated? 2016 ·Current Atherosclerosis Reports ·Barbara S. Wiggins, Joseph J. Saseen, Pamela B. Morris	11
11	High‐Impact Articles Related to the Management of Heart Failure: 2008 Update 2008 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Cynthia A. Jackevicius, Robert L. Page, Sheryl L. Chow, Steven P. Dunn, Craig R. Lee, Tien M. H. Ng, Jo E. Rodgers, Orly Vardeny, Barbara S. Wiggins, Mark Munger	7
12	Key Articles and Guidelines in the Management of Acute Coronary Syndromes and in Percutaneous Coronary Intervention: 2007 Update 2007 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Paul P. Dobesh, Sara D. Brouse, William E. Dager, Sarah A. Spinler, Zachary A. Stacy, Barbara S. Wiggins	3
13	Intraosseous Drug Administration in Children and Adults During Cardiopulmonary Resuscitation 2007 ·Annals of Pharmacotherapy ·Marcia L. Buck, Barbara S. Wiggins, (unknown)	89
14	Pharmacotherapy Considerations in Advanced Cardiac Life Support 2006 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·William E. Dager, Cynthia A. Sanoski, Barbara S. Wiggins, James E. Tisdale	12
15	Newer Pharmacotherapy in Patients Undergoing Percutaneous Coronary Interventions: A Guide for Pharmacists and Other Health Care Professionals 2006 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Glenn N. Levine, Peter B. Berger, David J. Cohen, Andrew Maree, Kenneth Rosenfield, Barbara S. Wiggins, Sarah A. Spinler	11
16	Role of P‐glycoprotein in Statin Drug Interactions 2006 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Carol W. Holtzman, Barbara S. Wiggins, Sarah A. Spinler	148
17	Bivalirudin: A Direct Thrombin Inhibitor for Percutaneous Transluminal Coronary Angioplasty 2002 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Barbara S. Wiggins, Sarah A. Spinler, Ann K. Wittkowsky, Kathleen A. Stringer	13
18	Clinical Use of New Antithrombotic Therapies for Medical Management of Acute Coronary Syndromes 2001 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Barbara S. Wiggins, Ann K. Wittkowsky, Jean M. Nappi	2
19	A Demonstration of Generalization of Performance Across Settings, Materials, and Motor Responses for Students with Profound Mental Retardation 1995 ·Behavior Modification ·Wendy K. Berg, David P. Wacker, (unknown), Barbara S. Wiggins, (unknown), (unknown)	11
20	TRAINING STUDENTS WITH PROFOUND OR MULTIPLE HANDICAPS TO MAKE REQUESTS VIA MICROSWITCHES 1988 ·Journal of Applied Behavior Analysis ·David P. Wacker, Barbara S. Wiggins, (unknown), Wendy K. Berg	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact